Cargando…
PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429028/ http://dx.doi.org/10.1097/01.HS9.0000977004.60504.4c |
| _version_ | 1785090613141569536 |
|---|---|
| author | Jun, LI Yao, Ding Yong, Zhang Zhanshu, Liu Yang, Zailin Zailiang, Yang Tingting, Liu Zhang, Xiaomei Liu, Yi Yifeng, Tang Fu, Huihui He, Sanxiu Liu, Yao |
| author_facet | Jun, LI Yao, Ding Yong, Zhang Zhanshu, Liu Yang, Zailin Zailiang, Yang Tingting, Liu Zhang, Xiaomei Liu, Yi Yifeng, Tang Fu, Huihui He, Sanxiu Liu, Yao |
| author_sort | Jun, LI |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429028 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290282023-08-17 PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY Jun, LI Yao, Ding Yong, Zhang Zhanshu, Liu Yang, Zailin Zailiang, Yang Tingting, Liu Zhang, Xiaomei Liu, Yi Yifeng, Tang Fu, Huihui He, Sanxiu Liu, Yao Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429028/ http://dx.doi.org/10.1097/01.HS9.0000977004.60504.4c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Jun, LI Yao, Ding Yong, Zhang Zhanshu, Liu Yang, Zailin Zailiang, Yang Tingting, Liu Zhang, Xiaomei Liu, Yi Yifeng, Tang Fu, Huihui He, Sanxiu Liu, Yao PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title | PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title_full | PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title_fullStr | PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title_full_unstemmed | PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title_short | PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY |
| title_sort | pb2578: antibody response to sars-cov-2 omicron variant in patients with hematological malignancies after the breakthrough infection wave in chongqing, china: a multi-center, prospective study |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429028/ http://dx.doi.org/10.1097/01.HS9.0000977004.60504.4c |
| work_keys_str_mv | AT junli pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT yaoding pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT yongzhang pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT zhanshuliu pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT yangzailin pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT zailiangyang pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT tingtingliu pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT zhangxiaomei pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT liuyi pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT yifengtang pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT fuhuihui pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT hesanxiu pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy AT liuyao pb2578antibodyresponsetosarscov2omicronvariantinpatientswithhematologicalmalignanciesafterthebreakthroughinfectionwaveinchongqingchinaamulticenterprospectivestudy |